Castleview Partners’s Acruence Active Hedge US Equity ETF XVOL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-52,691
Closed -$1.21M 224
2025
Q4
$1.21M Buy
+52,691
New +$1.23M 0.6% 38
2025
Q1
Sell
-6,055
Closed -$130K 590
2024
Q4
$130K Sell
6,055
-2
-0% -$45 0.07% 231
2024
Q3
$132K Sell
6,057
-50,989
-89% -$1.08M 0.08% 207
2024
Q2
$1.17M Sell
57,046
-745
-1% -$15K 0.67% 31
2024
Q1
$1.2M Sell
57,791
-1,272,636
-96% -$24.4M 0.67% 30
2023
Q4
$24.4M Buy
1,330,427
+134,041
+11% +$2.36M 17.08% 1
2023
Q3
$21.3M Buy
1,196,386
+601,142
+101% +$11.2M 19.65% 1
2023
Q2
$11.1M Buy
595,244
+4,435
+0.8% +$80.5K 10.04% 2
2023
Q1
$10.7M Buy
590,809
+32,466
+6% +$576K 9.5% 1
2022
Q4
$9.63M Buy
558,343
+28,927
+5% +$514K 9.38% 1
2022
Q3
$8.92M Buy
529,416
+528,416
+52,842% +$9.82M 8.52% 1
2022
Q2
$508 Sell
1,000
-542,393
-100% -$10.5M ﹤0.01% 725
2022
Q1
$11.6M Sell
543,393
-11,029,605
-95% -$232M 7.21% 3
2021
Q4
$517K Buy
+11,572,998
New +$253M 4.13% 6

Other funds holding XVOL

Castleview Partners's XVOL Position: Q1 2026 in Review

Castleview Partners sold out of Acruence Active Hedge US Equity ETF (XVOL) in Q1 2026, closing a stake of 52,691 shares — an estimated $1.21M sold.

Castleview Partners first reported a position in XVOL in Q4 2021 and held it in 14 quarters. The position peaked at $24.4M in Q4 2023. 3 funds tracked by Wall St. Rank hold XVOL as of Q1 2026.

  • Castleview Partners reported no remaining Acruence Active Hedge US Equity ETF position as of Q1 2026 after selling out during the quarter.
  • Castleview Partners sold 52,691 Acruence Active Hedge US Equity ETF shares in Q1 2026, an estimated $1.21M.
  • Castleview Partners first reported a position in Acruence Active Hedge US Equity ETF in Q4 2021 and held it in 14 quarters.
  • Castleview Partners's Acruence Active Hedge US Equity ETF position peaked at $24.4M in Q4 2023.
  • 3 funds tracked by Wall St. Rank held Acruence Active Hedge US Equity ETF as of Q1 2026.

Based on Castleview Partners's 13F filing for Q1 2026, filed 1 May 2026.